Projects

Reducing AIDS stigma among health professionals in India

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2013 - 2013

Project Lead

Dr. Maria Ekstrand, Dr. K Srinivasan, Dr. Tony Raj

Authors

Dr. Maria Ekstrand, Dr. K Srinivasan, Dr. Tony Raj

Project Status

completed

Project Type

National Institutes of Health (NIH), USA